Disrupted inhibitory interneuron development in SCN1A Dravet syndrome revealed by patient‐derived subpallial organoids
Epilepsia · 2026-08 · 67 (8) · 4380-4392
DOI: 10.1002/epi.70267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 05.05.2026. Verfasst von Cristiana Mattei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: NAV1.1 Voltage-Gated Sodium Channel, Interneurons, Organoids, Epilepsies, Myoclonic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy caused by loss‐of‐function variants in SCN1A , with seizures typically emerging during the first year of life. Although DS pathophysiology has largely been attributed to inhibitory network dysfunction underlying seizures, early developmental alterations in inhibitory interneurons remain poorly understood.
Methods
We generated inhibitory interneuron‐enriched subpallial organoids from patient‐derived induced pluripotent stem cells carrying an SCN1A loss‐of‐function variant and the corresponding isogenic control. Using complementary molecular and functional approaches, including quantitative polymerase chain reaction, bulk RNA sequencing, whole‐cell patch‐clamp electrophysiology, and two‐photon calcium imaging, we investigated early inhibitory interneuron development and functional maturation in a human cellular context.
Results
Transcriptomic profiling revealed early dysregulation of ventral forebrain interneuron developmental programs, including altered expression of medial ganglionic eminence‐associated transcriptional regulators, preceding inhibitory network dysfunction. Patient‐derived organoids exhibited marked reductions in intrinsic neuronal excitability and synaptic activity. Acute application of fenfluramine, a clinically approved antiseizure medication for DS, partially restored neuronal activity, demonstrating the translational relevance of this model. Significance These findings demonstrate that SCN1A loss of function disrupts early inhibitory interneuron development and functional maturation, defining a developmental vulnerability that likely precedes the emergence of epilepsy in DS. This work establishes patient‐derived inhibitory organoids as a human‐relevant platform for dissecting disease mechanisms and evaluating therapeutic responses in SCN1A ‐related epileptic encephalopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
- Austin Health, University of Melbourne, Melbourne, Victoria, Australia.
- Praxis Precision Medicines, Cambridge, Massachusetts, USA.
ORCID-Profile: Kay Richards, Snezana Maljevic
Zitieren
APA
Mattei, C., Mao, M., Byars, S., Syazwan, E. M., Oliva, M., Karle, T. J., Richards, K., Scheffer, I. E., Petrou, S., & Maljevic, S. (2026). Disrupted inhibitory interneuron development in SCN1A Dravet syndrome revealed by patient‐derived subpallial organoids. Epilepsia, 67(8), 4380-4392. https://doi.org/10.1002/epi.70267
Vancouver
Mattei C, Mao M, Byars S, Syazwan EM, Oliva M, Karle TJ, et al. Disrupted inhibitory interneuron development in SCN1A Dravet syndrome revealed by patient‐derived subpallial organoids. Epilepsia. 2026;67(8):4380-4392. doi:10.1002/epi.70267
BibTeX
@article{Mattei2026,
author = {Mattei, Cristiana and Mao, Miaomiao and Byars, Sean and Syazwan, Erlina Mohamed and Oliva, Megan and Karle, Timothy J and Richards, Kay and Scheffer, Ingrid E and Petrou, Steven and Maljevic, Snezana},
title = {Disrupted inhibitory interneuron development in SCN1A Dravet syndrome revealed by patient‐derived subpallial organoids},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {8},
pages = {4380--4392},
doi = {10.1002/epi.70267}
}
EUVIMED